The Advance Agrolife IPO will open on September 30, 2025, and close on October 3, 2025. This is a Book Built Issue aimed at raising approximately ₹192.86 crores, comprising a fresh issue of ₹192.86 crores along with an offer for sale of [.] equity shares, each carrying a face value of ₹10.

The price band has been fixed at ₹95 to ₹100 per share. The IPO allocation includes 35% for retail investors, 50% for Qualified Institutional Buyers (QIB), and 15% for High Net-worth Individuals (HNI). The shares are scheduled to list on BSE and NSE on October 8, 2025, with the allotment date set for October 6, 2025.

Financially, the company recorded ₹502.88 crores in revenue for 2025, compared to ₹457.21 crores in 2024, and reported a profit of ₹25.64 crores in 2025, slightly up from ₹24.73 crores in 2024. Based on these financials, long-term investment in this IPO is recommended.

About Advance Agrolife IPO

Incorporated in February 2002, Advance Agrolife is engaged in the manufacturing of a wide range of agrochemical products that aid the growth cycle of crops. Its products are used in the cultivation of cereals, vegetables, and horticultural crops across India. The company primarily focuses on producing high-performance insecticides, herbicides, fungicides, and plant growth regulators.

In addition, Advance Agrolife manufactures micro-nutrient fertilizers and bio-fertilizers. Most of its products are sold domestically through direct B2B sales to corporate customers. The company’s market presence covers 19 states and 3 union territories, and it exports to seven countries, including UAE, Bangladesh, China, Turkey, Egypt, Kenya, and Nepal. In FY24, it recorded ₹455 crore in operational revenue and a net profit after tax of ₹24 crore.